S 4482 New York Senate · 2019 Regular Session

Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry

Summary
Requires practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2019
Committee Review
Floor Vote
Governor
Introduced Mar 13, 2019 Last action Jan 8, 2020
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
2
Jan 8, 2020
Senate · Referred to committee
REFERRED TO HEALTH
Mar 13, 2019
Senate · Referred to committee
REFERRED TO HEALTH
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.